Pfizer Embraces Biotech-Like Speed To Advance BCMA Bispecific

Phase II Pivotal Trial Under Way For Elranatamab In Multiple Myeloma

3D Rendering of abstract highway path through digital binary towers in city
Pfizer is advancing its oncology pipeline with biotech-like speed and pharma scale • Source: Shutterstock

More from Strategy

More from Business